In this study, we investigated possible molecular mechanisms governing DNMT3b overexpression driving aberrant DNA hypermethylation, with a focus on miR-mediated regulation of DNMT3b in basal-like breast cancers. The gene discussed is DNMT3B; the disease is breast carcinoma.